Cite
HARVARD Citation
Reilmann, R. et al. (n.d.). N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial. Journal of neurology, neurosurgery and psychiatry. p. A102. [Online].